Do higher remnant cholesterol levels predict cardiovascular outcomes in non-myocardial infarction patients undergoing percutaneous coronary intervention?
In non-MI patients undergoing PCI, elevated remnant cholesterol is a marker for incident ischemic events like MI, despite lacking an association with overall MACE.
While RC did not associate with the composite MACE endpoint, higher concentrations of this subtype of triglyceride-rich lipoproteins was a marker for incident ischemic endpoints such as MI in patients undergoing PCI for a non-MI.
Pitaro et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: